What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...

Veracyte, Inc. , a leading genomic diagnostics company, today announced the publication of two studies demonstrating the Afirma GRID (Genomic Resource for Intelligent Discovery) research tool's ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.